AU Stock MarketDetailed Quotes
PYC PYC Therapeutics Ltd
- 0.110
- +0.005+4.76%
20min DelayNot Open Jul 23 16:00 AET
513.27MMarket Cap-15714P/E (Static)
0.110High0.105Low3.03MVolume0.110Open0.105Pre Close330.75KTurnover0.13552wk High0.16%Turnover Ratio4.67BShares0.05252wk Low-0.006EPS TTM213.77MFloat Cap0.860Historical HighLossP/E (Static)1.94BShs Float0.010Historical Low-0.007EPS LYR4.76%Amplitude--Dividend TTM18.33P/B1Lot Size--Div YieldTTM
About PYC Therapeutics Ltd Company
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company’s drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
Company Profile
SymbolPYC
Company NamePYC Therapeutics Ltd
Founded2001
MarketASX
Employees5
Fiscal Year Ends06-30
Address6 Verdun Street Harry Perkins Institute of Medical Research
CityPerth
CountryAustralia
Zip Code6009
Phone+61 861510992
Websitehttps://www.pyctx.com
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Rohan Hockings
- Executive Director,Chief Executive Officer
- --
- Alan William Tribe
- Non-Executive Chairman,Non-Executive Director
- --
- Michael Rosenblatt
- Non-Executive Director
- --
- Jason Haddock
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg